Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1977-10-14
|
pubmed:abstractText |
Elimination half-life times, plasma concentrations, and minimal cumulation factors are being determined resp. calculated for trimethoprime and sulfametrole (free as well as total amounts)--both combination partners of Lidaprim--in healthy volunteers and in patients with impaired renal function. There is a strong influence of renal function on the cumulation of the metabolized part of the sulfonamide, a weaker one on trimethoprime, and almost none on the free sulfonamide. On account of the sulfonamide metabolite cumulation, a reduction by half of the standard dose of Lidaprim is recommended if the creatinine clearance is below 20-30 ml/min.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0340-0026
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
310-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:892947-Adult,
pubmed-meshheading:892947-Aged,
pubmed-meshheading:892947-Creatinine,
pubmed-meshheading:892947-Drug Combinations,
pubmed-meshheading:892947-Female,
pubmed-meshheading:892947-Half-Life,
pubmed-meshheading:892947-Humans,
pubmed-meshheading:892947-Kidney Diseases,
pubmed-meshheading:892947-Kinetics,
pubmed-meshheading:892947-Male,
pubmed-meshheading:892947-Middle Aged,
pubmed-meshheading:892947-Sulfanilamides,
pubmed-meshheading:892947-Time Factors,
pubmed-meshheading:892947-Trimethoprim
|
pubmed:year |
1977
|
pubmed:articleTitle |
Pharmacokinetics of Lidaprim in cases of impaired renal function.
|
pubmed:publicationType |
Journal Article
|